Share
ATCC is committed to providing scientists with the credible, cutting-edge models they need to make breakthroughs in diagnostics development, drug discovery, toxicology profiling, analytical testing, and more. Explore our coming soon products by application for a preview of what our team is developing.
Oncology Cell biology Virology Molecular diagnostics
Oncology Products
Immuno-oncology Checkpoint Luciferase Reporter Cells
ATCC is developing a portfolio of luciferase reporter cells with high endogenous expression of immune checkpoint molecules.
- Wide range of targets such as PD-L1/2, CD-155, B7-H3, and PD-1
- Luciferase will be expressed under the control of GAS, NFAT, or NFκB
- Exceptional in vitro and ex vivo assay sensitivity and reproducibility
| Product Description | Availability |
|---|---|
| Checkpoint (PD-L1) tumor cell reporter – GAS-Luc2 (ATCC CRL-2868-GAS-Luc2) | Available now |
| Checkpoint (B7-H3) tumor cell reporter – GAS-Luc2 | Summer 2023 |
| Checkpoint (CD-155) tumor cell reporter – GAS-Luc2 | Summer 2023 |
| Checkpoint (PD-1) T cell reporter - NFAT-Luc2 | Fall 2023 |
Sign up for early access and beta-testing opportunities or to be notified when these products are available!
Cell Biology Products
Human Brown and White Pre-adipocytes – Available Summer 2023
Brown adipose cells (BAT) are critical tools for developing therapeutic solutions to metabolic diseases. However, there are few validated cell lines and access to primary tissue is limited. We are overcoming these limitations by developing hTERT-immortalized brown and white pre-adipocytes.
- Derived from a single donor
- Cells express the growth characteristics of a continuous cell but maintain primary cell functionality
- Can be differentiated into adipocytes
Sign up for early access and beta-testing opportunities or to be notified when these products are available!
Virology Products
SARS-CoV-2 Products
Explore the upcoming additions to our portfolio of SARS-CoV-2 reference materials.
| Product Description | Availability |
|---|---|
| Genomic RNA from SARS-CoV-2 strain USA/COR-22-063113/2022 (Omicron variant, lineage BA.5) | Spring 2023 |
| Heat-inactivated SARS-CoV-2 strain USA/COR-22-063113/2022 (Omicron variant, lineage BA.5) (ATCC VR-3378HK) | Available now |
| Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5AA7 | Spring 2023 |
| Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5AB3 | Spring 2023 |
| Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5AD5 | Spring 2023 |
| Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5AD9 | Spring 2023 |
| Monoclonal antibody, Anti-SARS-CoV-2 Full Length Spike protein-Clone 5BB4 | Spring 2023 |
Highly Purified Viruses
ATCC is developing highly purified viral spike-ins provided with reference-quality whole-genome sequences.
- High infectious titer
- High purity
- Thorough characterization
| Product Description | Availability |
|---|---|
| Minute virus of mice | Winter 2023 |
| Pseudorabies virus | Winter 2023 |
| Reovirus 3 | Winter 2023 |
| Xenotropic murine leukemia virus-related virus (xMuLV) | Winter 2023 |
Sign up to be the first to know when these products are ready!
Molecular Diagnostics Products
Molecular Standards
Check out the ready-to-use, fully authenticated standards we will be adding to our portfolio.
- Genomic nucleic acids comprise whole-genome preparations isolated from minimally passaged ATCC cultures
- Synthetic nucleic acids include key target regions from select species
| Product Description | Availability |
|---|---|
| Quantitative Genomic DNA from BK polyomavirus (ATCC VR-837DQ) |
Available now |
| Quantitative Genomic DNA from Canid herpesvirus 1 strain D 004 (ATCC VR-552DQ) | Available now |
| Quantitative Genomic RNA from Rubella virus strain M33 (ATCC VR-315DQ) | Available now |
| Quantitative Genomic DNA from Acinetobacter baumannii strain 2208 | Summer 2023 |
| Quantitative Genomic DNA from Clostridioides difficile strain 90556-M6S | Summer 2023 |
| Quantitative Genomic DNA from Vibrio parahaemolyticus strain EB101 | Summer 2023 |
| Quantitative Genomic DNA from Yersinia enterocolitica strain 33114 | Summer 2023 |
| Quantitative Genomic DNA from Chlamydia trachomatis strain UW-43/Cx | Fall 2023 |
| Quantitative Genomic DNA from Clostridioides difficile | Fall 2023 |
| Quantitative Genomic DNA from Neisseria gonorrhoeae strain F-18 | Fall 2023 |
| Quantitative Genomic DNA from Neisseria gonorrhoeae strain NCTC 8375 | Fall 2023 |
| Quantitative Genomic DNA from Peptostreptococcus anaerobius strain VPI 4330 |
Fall 2023 |
| Quantitative Genomic DNA from Plesiomonas shigelloides strain CDC 3085-55 | Fall 2023 |
| Quantitative Genomic DNA from Serratia marcescens subsp. marcescens strain BS 303 | Fall 2023 |
| Quantitative Genomic DNA from Streptococcus salivarius subsp. salivarius strain C699 | Fall 2023 |
| Quantitative Genomic DNA from Trichomonas vaginalis strain CDC 085 |
Fall 2023 |
| Quantitative Genomic RNA from Measles virus strain Edmonston | Fall 2023 |
| Quantitative Genomic DNA from Bacillus atrophaeus strain NRS 1221A | Winter 2023 |
| Quantitative Genomic DNA from Human Adenovirus D strain Trim | Winter 2023 |
| Quantitative Genomic DNA from Lactobacillus acidophilus strain SCAV | Winter 2023 |
| Quantitative Genomic DNA from Salmonella enterica subsp. enterica strain CDC K-1891 | Winter 2023 |
| Quantitative Synthetic RNA for Influenza A virus (H1N1) strain A/Brisbane/59/07 |
Winter 2023 |
| Quantitative Synthetic RNA for Influenza A virus (H1N1)pdm2009 strain A/Brisbane/02/2018 |
Winter 2023 |
| Quantitative Synthetic RNA for Influenza A virus (H3N2) strain A/Hiroshima/52/2005 | Winter 2023 |
| Quantitative Synthetic RNA for Influenza B virus strain B/Brisbane/60/2008 | Winter 2023 |
| Quantitative Synthetic RNA for Influenza B virus strain B/Malaysia/2506/2004 |
Winter 2023 |
Microbial panels
We are developing microbial panels comprising quantitative genomic molecular standards. The panels will be offered at bulk discount pricing, allowing you to take advantage of cost savings as compared to individual items.
| Product Description | Availability |
|---|---|
| Enteric exclusivity panel | Fall 2023 |
| Enteric pathogen panel | Fall 2023 |
| Sexually transmitted infection (STI) exclusivity panel |
Fall 2023 |
| Sexually transmitted infection (STI) pathogen panel | Fall 2023 |
Want more information about these products or to be notified when they are ready? Join our list!
Contact us
Your form was successfully submitted
